Ligand Pharmaceuticals Incorporated (LGND) — Fair Value Analysis

Base-case fair value (P50): $208.20 · Current price: $213.21 · Verdict: Fairly Valued

The Verdict on LGND

LIGAND PHARMACEUTICALS INC (LGND) currently appears Fairly Valued based on our rigorous Monte Carlo simulations. With the stock trading at $213.21, our median fair value (P50) stands at $208.20. This indicates an -2.3% difference, suggesting that LGND's market price is closely aligned with its intrinsic value as derived from thousands of forward-looking financial scenarios. Our analysis integrates a comprehensive range of potential outcomes, pointing to a balanced risk-reward profile at the current market level, which is reflected in the tight proximity of $213.21 to our P50 estimate.

How LGND stacks up against peers

LGND’s operational and financial health is assessed as an average quality tier compared to its sector peers. This average standing is a key input into our fair value calculations, as it moderates the potential upside from more robust companies while limiting the downside associated with lower-quality names. The fact that LGND's $213.21 closely mirrors our $208.20 estimate is consistent with its average quality tier, suggesting that the market is appropriately pricing in its current fundamental strength relative to the competitive landscape. An average quality firm with limited -2.3% against its fair value often signals a market that has already incorporated known strengths and weaknesses.

What this means for investors

For investors, LGND's Fairly Valued status, with its market price of $213.21 showing an -2.3% against our $208.20 median fair value, suggests that significant immediate alpha generation based purely on valuation arbitrage may be limited. While our Monte Carlo model explores a wide spectrum of outcomes, the primary takeaway is that LGND is neither significantly overvalued nor undervalued at this point. Investors seeking a clearer picture of LGND's specific downside scenario (P10) or more optimistic bull case (P90) distribution should leverage the full capabilities of FairCurve. To see the complete bear/bull distribution and track LGND's fair value as new fundamentals are released, sign up for a FairCurve account.